PDL BioPharma, Inc. Business Combination, Consideration Transferred, Other
PDL BioPharma, Inc. reported Business Combination, Consideration Transferred, Other of $47.36 million for the 0-month period ending 2016-07-02, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredOther1 · last filed 2017-11-13
- 2016-07-02: Business Combination, Consideration Transferred, Other 0 month $47.36M.
| Period end | Business Combination, Consideration Transferred, Other 0 month |
|---|---|
| 2016-07-02 | $47.36M 10-Q · filed 2017-11-13 |